Michael Burgess actually said...

Everybody on this committee needs to know that we can't do anything that drives innovation to another country like China that could cause us...

As a physician, I am uncomfortable with the idea of government action restricting American patients' access to lifesaving medications.

H.R. 3 is a proposal that was drafted behind closed doors by Speaker Pelosi and is being forced through this committee by the chairman.

This committee has a history of working in a bipartisan manner to improve generic and biosimilar competition.